SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,613 | -27.6% | 14,412 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $141,641 | +424.6% | 13,900 | +240.8% | 0.00% | – |
| Q1 2021 | $27,000 | +22.7% | 4,079 | +0.3% | 0.00% | – |
| Q4 2020 | $22,000 | -29.0% | 4,068 | -2.8% | 0.00% | – |
| Q3 2020 | $31,000 | +29.2% | 4,186 | +27.4% | 0.00% | – |
| Q2 2020 | $24,000 | +84.6% | 3,287 | -24.2% | 0.00% | – |
| Q1 2019 | $13,000 | -23.5% | 4,338 | -3.1% | 0.00% | – |
| Q4 2018 | $17,000 | -34.6% | 4,478 | -0.8% | 0.00% | – |
| Q3 2018 | $26,000 | +4.0% | 4,513 | +1.9% | 0.00% | – |
| Q2 2018 | $25,000 | -56.9% | 4,431 | -5.9% | 0.00% | – |
| Q1 2018 | $58,000 | – | 4,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,247,005 | $10,358,000 | 0.56% |
| Orbimed Advisors | 3,409,865 | $10,877,000 | 0.17% |
| Eversept Partners, LP | 174,297 | $556,007 | 0.16% |
| Alambic Investment Management, L.P. | 59,847 | $191,000 | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,500 | $196,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 36,921 | $118,000 | 0.00% |
| Paloma Partners Management Co | 30,000 | $96,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,211 | $10,000 | 0.00% |
| SG Americas Securities, LLC | 12,877 | $41,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 967 | $3,000 | 0.00% |